Diphenhydramine tannate compositions and methods of use

Abstract

A therapeutic composition comprises diphenhydramine tannate in the substantial absence of other active ingredients. The composition has utility in providing symptomatic relief of sneezing, itchy, watery eyes, itchy nose or throat and runny nose due to hay fever (allergic rhinitis) or other respiratory allergies.

What is claimed is:  
     
         1 . A therapeutic composition comprising as an active ingredient a pharmaceutically effective amount of diphenhydramine tannate in substantial absence of other active ingredients.  
     
     
         2 . The therapeutic composition of  claim 1 , further including an excipient.  
     
     
         3 . The therapeutic composition of  claim 2 , wherein said excipient is selected from a group consisting of microcrystalline cellulose, lactose, sugar, magnesium aluminum silicate, xanthan gum, polyvinylpyrrolidone, cellulose, starch, starch hydroxypropyl methylcellulose, sucrose, saccharin sodium, calcium phosphate, talc, magnesium stearate, artificial flavor, kaolin, pectin, glycerine, sodium citrate, sodium phosphate monobasic and dibasic, citric acid, methylparaben, sodium benzoate, benzoic acid, coloring agents, purified water and mixtures thereof.  
     
     
         4 . The therapeutic composition of  claim 1 , in a liquid dosage form.  
     
     
         5 . The therapeutic composition of  claim 1 , in a semisolid dosage form.  
     
     
         6 . The therapeutic composition of  claim 1 , in a solid dosage form.  
     
     
         7 . The therapeutic composition of  claim 1 , in a tablet form.  
     
     
         8 . The therapeutic composition of  claim 1 , in a capsule form.  
     
     
         9 . A therapeutic composition, consisting essentially of a pharmaceutically effective amount of diphenhydramine tannate.  
     
     
         10 . The therapeutic composition of  claim 9 , further including an excipient.  
     
     
         11 . The therapeutic composition of  claim 10 , wherein said excipient is selected from a group consisting of microcrystalline cellulose, lactose, sugar, magnesium aluminum silicate, xanthan gum, polyvinylpyrrolidone, cellulose, starch, starch hydroxypropyl methylcellulose, sucrose, saccharin sodium, calcium phosphate, talc, magnesium stearate, artificial flavor, kaolin, pectin, glycerine, sodium citrate, sodium phosphate monobasic and dibasic, citric acid, methylparaben, sodium benzoate, benzoic acid, coloring agents, purified water and mixtures thereof.  
     
     
         12 . The therapeutic composition of  claim 9 , in a liquid dosage form.  
     
     
         13 . The therapeutic composition of  claim 9 , in a semisolid dosage form.  
     
     
         14 . The therapeutic composition of  claim 9 , in a solid dosage form.  
     
     
         15 . The therapeutic composition of  claim 9 , in a tablet form.  
     
     
         16 . The therapeutic composition of  claim 9 , in a capsule form.  
     
     
         17 . A method for symptomatically treating respiratory allergies in a warm-blooded animal, comprising administering to said warm-blooded animal a pharmaceutically effective amount of diphenhydramine tannate in substantial absence of other active ingredients.  
     
     
         18 . A method for symptomatically treating respiratory allergies in a warm-blooded animal, consisting essentially of administering to said warm-blooded animal a pharmaceutically effective amount of diphenhydramine tannate.